SE8800461L - Farmaceutisk komposition - Google Patents

Farmaceutisk komposition

Info

Publication number
SE8800461L
SE8800461L SE8800461A SE8800461A SE8800461L SE 8800461 L SE8800461 L SE 8800461L SE 8800461 A SE8800461 A SE 8800461A SE 8800461 A SE8800461 A SE 8800461A SE 8800461 L SE8800461 L SE 8800461L
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
therapeutically active
active amount
amount
therapeutic
Prior art date
Application number
SE8800461A
Other languages
English (en)
Other versions
SE8800461D0 (sv
SE461013B (sv
Inventor
Christian Wesslau
Ulf Per Gustav Smith
Original Assignee
Christian Wesslau
Ulf Per Gustav Smith
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Christian Wesslau, Ulf Per Gustav Smith filed Critical Christian Wesslau
Priority to SE8800461A priority Critical patent/SE461013B/sv
Publication of SE8800461D0 publication Critical patent/SE8800461D0/sv
Priority to EP89902559A priority patent/EP0357725B1/en
Priority to DE8989902559T priority patent/DE68901234D1/de
Priority to AT89902559T priority patent/ATE74767T1/de
Priority to JP1502359A priority patent/JPH03500294A/ja
Priority to PCT/SE1989/000057 priority patent/WO1989007454A1/en
Publication of SE8800461L publication Critical patent/SE8800461L/sv
Priority to NO89894030A priority patent/NO894030L/no
Priority to DK500589A priority patent/DK500589D0/da
Priority to FI894809A priority patent/FI894809A0/fi
Publication of SE461013B publication Critical patent/SE461013B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SE8800461A 1988-02-11 1988-02-11 Farmaceutisk komposition verksam mot lungobstruktioner bestaaende av en betaadrenerg antagonist och ett tyroideahormon SE461013B (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE8800461A SE461013B (sv) 1988-02-11 1988-02-11 Farmaceutisk komposition verksam mot lungobstruktioner bestaaende av en betaadrenerg antagonist och ett tyroideahormon
PCT/SE1989/000057 WO1989007454A1 (en) 1988-02-11 1989-02-10 Pharmaceutical composition for treatment of lung obstructions
JP1502359A JPH03500294A (ja) 1988-02-11 1989-02-10 肺閉鎖症の治療用薬剤組成物
DE8989902559T DE68901234D1 (de) 1988-02-11 1989-02-10 Arzneimittelzusammensetzung zur behandlung des lungenverstopfens.
AT89902559T ATE74767T1 (de) 1988-02-11 1989-02-10 Arzneimittelzusammensetzung zur behandlung des lungenverstopfens.
EP89902559A EP0357725B1 (en) 1988-02-11 1989-02-10 Pharmaceutical composition for treatment of lung obstructions
NO89894030A NO894030L (no) 1988-02-11 1989-10-09 Farmasoeytisk blanding for behandling av lungeobstruksjoner
DK500589A DK500589D0 (da) 1988-02-11 1989-10-10 Farmaceutisk praeparat til behandling af lungeobstruktioner
FI894809A FI894809A0 (fi) 1988-02-11 1989-10-10 Farmakologisk komposition foer behandling av lungobstruens.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8800461A SE461013B (sv) 1988-02-11 1988-02-11 Farmaceutisk komposition verksam mot lungobstruktioner bestaaende av en betaadrenerg antagonist och ett tyroideahormon

Publications (3)

Publication Number Publication Date
SE8800461D0 SE8800461D0 (sv) 1988-02-11
SE8800461L true SE8800461L (sv) 1989-08-12
SE461013B SE461013B (sv) 1989-12-18

Family

ID=20371349

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8800461A SE461013B (sv) 1988-02-11 1988-02-11 Farmaceutisk komposition verksam mot lungobstruktioner bestaaende av en betaadrenerg antagonist och ett tyroideahormon

Country Status (6)

Country Link
EP (1) EP0357725B1 (sv)
JP (1) JPH03500294A (sv)
DK (1) DK500589D0 (sv)
FI (1) FI894809A0 (sv)
SE (1) SE461013B (sv)
WO (1) WO1989007454A1 (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0466909B1 (en) * 1990-02-05 1995-06-28 British Technology Group (Usa) Incorporated Thyroid hormone for cardiac treatment
US5158978A (en) * 1990-02-05 1992-10-27 British Technology Group (U.S.A.) Thyroid hormone treatment of acute cardiovascular compromise
DK0678122T3 (da) 1993-01-12 2000-03-06 Biogen Inc Rekombinante anti-VLA4 antistofmolekyler
ATE390919T1 (de) * 2004-11-18 2008-04-15 Uni Pharma Kleon Tsetis Pharmaceutical Lab Sa Trockenpulver mit levothyroxin-natrium mit verabreichung über einen inhalator
US20140161794A1 (en) 2010-04-16 2014-06-12 Biogen Idec Ma Inc. Anti-vla-4 antibodies
CN112867394B (zh) 2018-06-04 2024-09-13 马萨诸塞州渤健公司 具有降低的效应功能的抗vla-4抗体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH622703A5 (en) * 1976-06-10 1981-04-30 Berema Sa Therapeutic compositions for treating deposits of excess fat and infiltrates causing cellulite
FR2357246A1 (fr) * 1976-07-09 1978-02-03 Martinez Gerard Nouvelles compositions therapeutiques douees d'activite anti-inflammatoire, antalgique et anti-cellulitique
US4086363A (en) * 1977-03-16 1978-04-25 Usv Pharmaceutical Corporation Treatment of asthma
DE3237253A1 (de) * 1981-12-23 1983-10-06 Forschinst Lungen & Tuberkulos Mittel zur beseitigung und verhinderung von belastungsinduzierten und analgetikainduzierten asthma-bronchiale-anfaellen

Also Published As

Publication number Publication date
EP0357725A1 (en) 1990-03-14
JPH03500294A (ja) 1991-01-24
WO1989007454A1 (en) 1989-08-24
DK500589A (da) 1989-10-10
EP0357725B1 (en) 1992-04-15
SE8800461D0 (sv) 1988-02-11
SE461013B (sv) 1989-12-18
FI894809A0 (fi) 1989-10-10
DK500589D0 (da) 1989-10-10

Similar Documents

Publication Publication Date Title
BR9106977A (pt) Metodo para suprimir destruicao autoimune de celuias beta pancreaticas,formulacao farmaceutica,metodo de profilaxia,metodo para prevenir o surgimento de diabetes tipo 1 e metodo para tratar um mamifero
IT1255258B (it) Composizioni farmaceutiche per l'applicazione per via nasale.
FI851336A0 (fi) Ny fysiologiskt aktiv human polypeptid.
ATE46080T1 (de) Pharmazeutische komposition.
NO161002C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider.
NO162113C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminforbindelser.
NO166367C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno-1,4-diazepiner.
NO872946D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzensulfonamidoindanylforbindelser.
NO161317C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oksikamer.
NO154492C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme forbindelser.
NO912558L (no) Mucoadhesiv baerer for avlevering av terapeutiske midler.
NO158460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO165071C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-(3-amino-1-pyrrolidinyl)-8-klor-1-cyklopropyl-6- fluor-1,4,-dihydro-4-okso-3-kinolin-karboksylsyre.
DK376188A (da) Farmaceutisk dosisenhed
NO163775C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolinyl-alkyl-piperaziner.
NO158417C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive urinstoffer og tiourinstoffer.
SE8800461L (sv) Farmaceutisk komposition
NO894949D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzopyranylpyrrolinonderivater.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.
ES2019634B3 (es) Terapia con clorfeniramina.
NO168477C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte diazepinoner.
NO165542C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.
NO168530C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazoninforbindelser.
NO903939L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte diazepinoner.
NO164973C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo- og tetrahalo-1,2-diamino-4,9,-diaza-dodecaner.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8800461-9

Effective date: 19930912

Format of ref document f/p: F